[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 68, "title": "Chief Legal Officer, Chief Compliance Officer & Secretary", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 737771, "exercisedValue": 0, "unexercisedValue": 255600}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 58, "title": "Senior Vice President of Information Technology & Human Resources", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl N. Kraus M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Melina T. Cioffi Pharm.D.", "age": 41, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Charles Arnold", "title": "VP of Finance, Controller & Assistant Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.11, "open": 4.17, "dayLow": 4.03, "dayHigh": 4.205, "regularMarketPreviousClose": 4.11, "regularMarketOpen": 4.17, "regularMarketDayLow": 4.03, "regularMarketDayHigh": 4.205, "payoutRatio": 0.0, "beta": 1.987, "forwardPE": -6.85, "volume": 1701209, "regularMarketVolume": 1701209, "averageVolume": 1370624, "averageVolume10days": 1517960, "averageDailyVolume10Day": 1517960, "bid": 2.99, "ask": 5.22, "bidSize": 2, "askSize": 2, "marketCap": 409864000, "fiftyTwoWeekLow": 2.12, "fiftyTwoWeekHigh": 5.8, "priceToSalesTrailing12Months": 9.28723, "fiftyDayAverage": 3.7668, "twoHundredDayAverage": 3.455675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 389586144, "profitMargins": -1.47381, "floatShares": 93930689, "sharesOutstanding": 99723600, "sharesShort": 9442487, "sharesShortPriorMonth": 11181713, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0951, "heldPercentInsiders": 0.05282, "heldPercentInstitutions": 0.52301997, "shortRatio": 8.41, "shortPercentOfFloat": 0.112799995, "impliedSharesOutstanding": 99723600, "bookValue": -0.731, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -65042000, "trailingEps": -0.69, "forwardEps": -0.6, "enterpriseToRevenue": 8.828, "enterpriseToEbitda": -7.493, "52WeekChange": -0.035211265, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 4.11, "targetHighPrice": 15.0, "targetLowPrice": 4.75, "targetMeanPrice": 8.41667, "targetMedianPrice": 8.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 60536000, "totalCashPerShare": 0.607, "ebitda": -51994000, "totalDebt": 40258000, "quickRatio": 3.127, "currentRatio": 3.529, "totalRevenue": 44132000, "revenuePerShare": 0.468, "returnOnAssets": -0.31118, "grossProfits": 26962000, "freeCashflow": -25946250, "operatingCashflow": -49683000, "revenueGrowth": -0.502, "grossMargins": 0.61094004, "ebitdaMargins": -1.17815, "operatingMargins": -1.1364601, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": -0.973235, "postMarketPrice": 4.07, "postMarketChange": -0.04, "regularMarketChange": 0.0, "regularMarketDayRange": "4.03 - 4.205", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1370624, "fiftyTwoWeekLowChange": 1.9900002, "fiftyTwoWeekLowChangePercent": 0.9386794, "fiftyTwoWeekRange": "2.12 - 5.8", "fiftyTwoWeekHighChange": -1.69, "fiftyTwoWeekHighChangePercent": -0.2913793, "fiftyTwoWeekChangePercent": -3.5211265, "earningsTimestamp": 1754942400, "earningsTimestampStart": 1762200000, "earningsTimestampEnd": 1762200000, "earningsCallTimestampStart": 1747137600, "earningsCallTimestampEnd": 1747137600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.69, "epsForward": -0.6, "epsCurrentYear": -0.58, "priceEpsCurrentYear": -7.0862074, "fiftyDayAverageChange": 0.3432002, "fiftyDayAverageChangePercent": 0.091111876, "twoHundredDayAverageChange": 0.65432525, "twoHundredDayAverageChangePercent": 0.18934803, "priceToBook": -5.622435, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 4.11, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "corporateActions": [], "postMarketTime": 1755300955, "regularMarketTime": 1755288001, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]